3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Carcinoma, Non-Small-Cell Lung
6
Breast Neoplasms
6
Rectal Neoplasms
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large-Cell, Anaplastic
5
Lung Neoplasms
5
Leukemia, Myeloid, Acute
5
Leukemia
5
Colonic Neoplasms
5
Multiple Myeloma
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Immunoblastic Lymphadenopathy
4
Colorectal Neoplasms
4
Burkitt Lymphoma
4
Waldenstrom Macroglobulinemia
3
Stomach Neoplasms
3
Sezary Syndrome
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hodgkin Disease
3
Esophageal Neoplasms
3
Congenital Abnormalities
3
Interventions
Pemetrexed
15
Cisplatin
13
pembrolizumab
6
Platinum
4
1,2-diaminocyclohexaneplatinum II citrate
4
cediranib
3
Radiotherapy
3
Gemcitabine
3
Carboplatin
3
amatuximab
2
Radiotherapy, Intensity-Modulated
2
Radiation
2
Everolimus
2
Drug Therapy
2
Cyclophosphamide
2
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
tremelimumab
1
sodium thiosulfate
1
sargramostim
1
nintedanib
1
napabucasin
1
methoxyamine
1
liposomal doxorubicin
1
incomplete Freund's adjuvant
1
fresolimumab
1
durvalumab
1
defactinib
1
cixutumumab
1
bintrafusp alfa protein, human
1
bemcentinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Mesothelioma, Malignant
×
Gene Expression Profiling
×
Clear all
No trials found.